Trade Mark Journal No.2026/026 26 June 2026
UK00004401712 12 June 2026 (5)
Nupharmisto
- Class 5
- Medicated preparations for skin treatment; Medicated skin care preparations; Acne treatment preparations; Preparations for the treatment of acne; Niacinamide preparations for the treatment of acne; Skin care (Pharmaceutical preparations for -); Pharmaceutical preparations for skin care; Pharmacological preparations for skin care; Acne creams [pharmaceutical preparations]; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for hydrating the skin during pregnancy; Pharmaceutical preparations for the treatment of Parkinson's disease; Acne cleansers [pharmaceutical preparations]; Acne cream [pharmaceutical preparations]; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of hypercholesteremia; Patches impregnated with acne treatment preparations; Pharmaceutical preparations for the treatment of hormonal disorders; Medicated hair care preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for the treatment of cancer; Dermatological preparations; Medicated mouth treatment preparations; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for hair care; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical preparations for the treatment of osteoporosis; Preparations for cleansing the skin for medical use; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of esophagitis; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for the treatment of inflammatory disorders.
Ryan Williams